Maine Molecular Quality Controls Offers First Commercially Available Genetic Test Controls for Hereditary Hemochromatosis
As FDA, CDC Announce Stricter Quality Guidelines,
Quality Control Innovator Expands Product Line
Scarborough, Maine – Even as the federal government said it will impose stricter quality standards for genetic testing, Maine Molecular Quality Controls Inc. (MMQCI) announced the availability of a new line of controls in support of diagnostic tests for mutations associated with hereditary hemochromatosis.
Read Full Article
Maine Molecular Quality Controls Expands
Cystic Fibrosis Test Panel Control to 79 Mutations
Maker of only FDA-cleared quality control for molecular CF test extends capacity, capability of labs with largest set of genetic mutations available
Scarborough, Maine – Further extending the ability of medical laboratories around the world to support in vitro diagnostic testing for cystic fibrosis, Maine Molecular Quality Controls Inc. (MMQCI) announces it has expanded the range of its synthetic multiplex control to a set of 79 mutations known to be associated with the deadly disease.
Read Full Article
